Trilogy Global Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,216,671
Closed -$14.7M 31
2018
Q3
$14.7M Buy
3,216,671
+193,534
+6% +$923K 1.64% 18
2018
Q2
$14M Sell
3,023,137
-173,141
-5% -$1.02M 1.38% 20
2018
Q1
$23.2M Sell
3,196,278
-324,350
-9% -$2.23M 2.15% 16
2017
Q4
$22.7M Buy
3,520,628
+1,507,347
+75% +$9.64M 1.44% 18
2017
Q3
$13.3M Sell
2,013,281
-3,935,355
-66% -$24.4M 0.84% 23
2017
Q2
$32.7M Sell
5,948,636
-8,538,359
-59% -$48.7M 1.1% 31
2017
Q1
$83.4M Sell
14,486,995
-2,839,169
-16% -$15.6M 2.79% 11
2016
Q4
$85.1M Sell
17,326,164
-98,139
-0.6% -$530K 2.86% 9
2016
Q3
$106M Buy
17,424,303
+554,639
+3% +$3.32M 3.51% 6
2016
Q2
$99.7M Sell
16,869,664
-962,401
-5% -$5.17M 3.07% 7
2016
Q1
$92.4M Buy
17,832,065
+1,958,295
+12% +$9.01M 2.55% 10
2015
Q4
$70.8M Buy
15,873,770
+4,017,284
+34% +$19.6M 1.84% 14
2015
Q3
$58.1M Sell
11,856,486
-2,745,402
-19% -$14.9M 1.57% 21
2015
Q2
$89.1M Buy
14,601,888
+117,276
+0.8% +$725K 1.85% 14
2015
Q1
$83.4M Sell
14,484,612
-2,482,808
-15% -$15.4M 1.79% 17
2014
Q4
$106M Buy
16,967,420
+360,987
+2% +$2.28M 2.19% 14
2014
Q3
$109M Sell
16,606,433
-2,749,154
-14% -$19.4M 2.3% 11
2014
Q2
$136M Buy
19,355,587
+3,914,797
+25% +$28.8M 2.6% 7
2014
Q1
$114M Buy
15,440,790
+4,559,020
+42% +$31.9M 2.29% 7
2013
Q4
$80M Buy
+10,881,770
New +$79.5M 1.63% 22

Other funds holding ABEV

Trilogy Global Advisors's ABEV Position: Q4 2018 in Review

Trilogy Global Advisors sold out of Ambev (ABEV) in Q4 2018, closing a stake of 3,216,671 shares — an estimated $14.7M sold.

Trilogy Global Advisors first reported a position in ABEV in Q4 2013 and held it in 20 quarters. The position peaked at $136M in Q2 2014. 318 funds tracked by Wall St. Rank hold ABEV as of Q4 2018.

  • Trilogy Global Advisors reported no remaining Ambev position as of Q4 2018 after selling out during the quarter.
  • Trilogy Global Advisors sold 3,216,671 Ambev shares in Q4 2018, an estimated $14.7M.
  • Trilogy Global Advisors first reported a position in Ambev in Q4 2013 and held it in 20 quarters.
  • Trilogy Global Advisors's Ambev position peaked at $136M in Q2 2014.
  • 318 funds tracked by Wall St. Rank held Ambev as of Q4 2018.

Based on Trilogy Global Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.